HOUSTON (AP) _ Alaunos Therapeutics, Inc. (TCRT) on Monday reported a loss of $9.8 million in its first quarter.

The Houston-based company said it had a loss of 5 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TCRT at https://www.zacks.com/ap/TCRT

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News